Ixekizumab: A Review of Its Use for the Management of Moderate to Severe Plaque Psoriasis

Objective: To review the efficacy, safety, and place in therapy of ixekizumab for the treatment of moderate to severe plaque psoriasis. Data Sources: PubMed (1966 to July 2018) and clinicaltrials.gov were searched using the terms ixekizumab, LY2439821, interleukin-17, and psoriasis. Study Selection...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of Pharmacotherapy 2019-03, Vol.53 (3), p.276-284
Hauptverfasser:	Shelton, Sydney K., Bai, Sandra R., Jordan, Joseph K., Sheehan, Amy Heck
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antibodies, Monoclonal, Humanized - administration & dosage Antibodies, Monoclonal, Humanized - adverse effects Antibodies, Monoclonal, Humanized - therapeutic use Female Humans Inflammatory Bowel Diseases - chemically induced Inflammatory Bowel Diseases - immunology Interleukin-17 - metabolism Male Middle Aged Psoriasis - drug therapy Psoriasis - immunology Risk Severity of Illness Index Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!